Targeting HIV-1 through molecular modeling and docking studies of CXCR4: Leads for therapeutic development

被引：19

作者：

Singh, Shailza ^{[1
]}

Malik, B. K.

Sharma, D. K.

机构：

[1] Indian Inst Technol, Ctr Energy Studies, New Delhi 110016, India

[2] CSIR, Inst Genom & Integrat Biol, New Delhi 110007, India

来源：

CHEMICAL BIOLOGY & DRUG DESIGN | 2007年 / 69卷 / 03期

关键词：

CXCR4; docking; flavonoids; human immunodeficiency virus; molecular modeling; AIDS-RELATED-COMPLEX; ENTRY INHIBITORS; ANTIRETROVIRAL THERAPY; CHEMOKINE RECEPTORS; AZIDOTHYMIDINE AZT; PROTEIN-STRUCTURE; CD4; RECEPTOR; DOUBLE-BLIND; MIP-1; ALPHA; VIRUS;

D O I：

10.1111/j.1747-0285.2007.00478.x

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The chemokine receptor CXCR4 is the receptor for several chemokines and major co-receptor for X4 human immunodeficiency virus type-1 strains entry into cell. A three-dimensional model of human CXCR4 was developed by homology modeling using the high-resolution bovine rhodopsin structure as template. Interactions between CXCR4 and flavonoids were investigated using in silico docking studies. The results underscore the potential of these compounds that they may become important new antiviral drugs to combat AIDS. It is worth mentioning also that apart from these existing flavonoids, there are many new compounds that may also be useful as topical agents to inactivate virus, or may act as adjuvants with other antiviral drugs.

引用

页码：191 / 203

页数：13

共 50 条

[41] Homology modeling and docking studies between HIV-1 protease and carbamic acid
Balakrishnan, M.
Srivastava, R. C.
Pokhriyal, Mayank
INDIAN JOURNAL OF BIOTECHNOLOGY, 2010, 9 (01): : 96 - 100
[42] Design, Synthesis, and Docking Studies of Thioimidazolyl Diketoacid Derivatives Targeting HIV-1 Integrase
Karimi, Nafiseh
Roudsari, Rouhollah Vahabpour
Hajimahdi, Zahra
Zarghi, Afshin
MEDICINAL CHEMISTRY, 2022, 18 (05) : 616 - 628
[43] Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4
M BouHamdan
DS Strayer
D Wei
M Mukhtar
L-X Duan
J Hoxie
RJ Pomerantz
Gene Therapy, 2001, 8 : 408 - 418
[44] Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4
BouHamdan, M
Strayer, DS
Wei, D
Mukhtar, M
Duan, LX
Hoxie, J
Pomerantz, RJ
GENE THERAPY, 2001, 8 (05) : 408 - 418
[45] Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South Africa
Matume, Nontokozo D.
Tebit, Denis M.
Gray, Laurie R.
Hammarskjold, Marie-Louise
Rekosh, David
Bessong, Pascal O.
JOURNAL OF CLINICAL VIROLOGY, 2018, 103 : 81 - 87
[46] Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry
Hatse, S
Princen, K
Vermeire, K
Gerlach, LO
Rosenkilde, MM
Schwartz, TW
Bridger, G
De Clercq, E
Schols, D
FEBS LETTERS, 2003, 546 (2-3) : 300 - 306
[47] Mimicking protein-protein interactions through peptide-peptide interactions: HIV-1 gp120 and CXCR4
Gross, Andrea
Moebius, Kalle
Haussner, Christina
Donhauser, Norbert
Schmidt, Barbara
Eichler, Jutta
FRONTIERS IN IMMUNOLOGY, 2013, 4
[48] Molecular docking studies of chromone derivatives against wild type and mutant strains of HIV-1 protease
Nunthanavanit, Patcharawee
Ungwitayatorn, Jiraporn
MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (09) : 4198 - 4208
[49] Study of the HIV-1 receptors CD4, CXCR4, CCR5 and CCR3 in the human and rat testis
Habasque, C
Aubry, F
Jégou, B
Samson, M
MOLECULAR HUMAN REPRODUCTION, 2002, 8 (05) : 419 - 425
[50] Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors
Vijay M. Khedkar
Premlata K. Ambre
Jitender Verma
Mushtaque S. Shaikh
Raghuvir R. S. Pissurlenkar
Evans C. Coutinho
Journal of Molecular Modeling, 2010, 16 : 1251 - 1268

← 1 2 3 4 5 →